News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC – Debyani Chakravarty
Photo taken from: Debyani Chakravarty / Twitter
Jul 17, 2023, 09:59

Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC – Debyani Chakravarty

My OncoKB people: Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC.

Looking fwd to it getting tumor agnostic approval based on Alison Schram work showing 42% ORR in PDAC (& 35% in NSCLC).

 

Source: Debyani Chakravarty / Twitter

FDA OncoDaily Oncology zenocutuzumab
Insight
Jul 4, 2024, 10:52
Myeloma Paper of the Day, July 4th, suggested by Robert Orlowski
Blog
Jul 4, 2024, 10:51
Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in
Positive
Jul 4, 2024, 10:46
Dr. Eytan Stein to lead a novel clinical trial for AML patients
Blog
Jul 4, 2024, 10:04
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Blog
Jul 4, 2024, 09:33
Wen Shen Looi: Thrilled to chair a couple of sessions and speak about radiotherapy for sarcomas at the SIOP-Asia
Blog
Jul 4, 2024, 09:24
Daniel Bastardo Blanco: XVI Childhood Cancer International LATAM Meeting brought together over 50 Latin American NGOs
Blog
Jul 4, 2024, 09:11
Caitríona Duggan: Research Agenda for Cancer Treatment for Intravenous devices with Clinicians in Europe
Blog
Jul 4, 2024, 09:05
EClinicalMedicine has published two articles highlighting the SIOP Europe 2024
Insight
Jul 4, 2024, 09:04
Esranur Aydın: A remarkable success in treating a heavily pretreated metastatic CRC patient
Blog
Jul 4, 2024, 08:53
Jan Cools: 2023 journal impact factor of HemaSphere Journal is 12.1
Insight
Jul 4, 2024, 08:53
$800,000 grant from the V Foundation to support Maria Abreu's innovative research on colorectal cancer
Blog
Jul 4, 2024, 08:41
Julie McCrossin: Exciting clinical innovation - FDA approved Adaptive Proton Therapy